Retraction: MicroRNA-497 inhibits thyroid cancer tumor growth and invasion by suppressing BDNF

Peisong Wang; Xianying Meng; Yan Huang; Zhi Lv; Jia Liu; Guimin Wang; Wei Meng; Shuai Xue; Qiang Zhang; Pengju Zhang; Guang Chen

doi:10.18632/oncotarget.28248

Oncotarget

On September 15, 2022, Oncotarget was accepted again for indexing by MEDLINE. Oncotarget is now indexed by Medline/PubMed and PMC/PubMed.
Learn more.

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Retraction:

Retraction: MicroRNA-497 inhibits thyroid cancer tumor growth and invasion by suppressing BDNF

PDF | How to cite

Oncotarget. 2022; 13:842-842. https://doi.org/10.18632/oncotarget.28248

Metrics: PDF 753 views | ?

Peisong Wang¹, Xianying Meng¹, Yan Huang², Zhi Lv², Jia Liu¹, Guimin Wang¹, Wei Meng¹, Shuai Xue¹, Qiang Zhang¹, Pengju Zhang^3,* and Guang Chen^1,*

¹Department of Thyroid Surgery, The First Hospital of Jilin University, Chaoyang District, Changchun 130021, China
²Department of Orthopaedic Surgery, China-Japan Union Hospital of Jilin University, Jingyue District, Changchun 130033, China
³Jilin Academy of Agricultural Sciences, Nanguan District, Changchun 130000, China
^*These authors have contributed equally to this work

Published: June 30, 2022

Copyright: © 2022 Wang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

This article has been retracted: Oncotarget has completed its investigation of this paper. We found that Figures 2C, 2E, 6B, and 6F contain similarities with data appearing in other articles by different authors. The data had already been published elsewhere, or were already under consideration for publication prior to submission to Oncotarget. On June 15, 2022 Oncotarget received a signed letter asking to retract the paper because certain experiments, including cell colony formation and in vivo assay, were unable to be reproduced. Oncotarget has notified the affiliated institution regarding this retraction.

Original article: Oncotarget. 2017; 8:2825–2834. DOI: https://doi.org/10.18632/oncotarget.13747.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 28248

Announcements

Publication Alerts

Retraction:

Retraction: MicroRNA-497 inhibits thyroid cancer tumor growth and invasion by suppressing BDNF